- Display 15 Products per page
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
Published: May 14, 2020 | Price: $4,000 – $8,000
CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
Published: April 7, 2020 | Price: $750 – $1,000
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...
Internet of Things (IoT) in Healthcare
Published: September 19, 2019 | Price: $5,000 – $10,000
By 2020, it is estimated that there will be 21 billion connected devices in the world. That will be five times as many as just four years ago. This fact affects healthcare as much as any industry. Internet of Things (IoT) in Healthcare tracks the trends around IoT in healthcare and makes specific market estimates and forecasts. The industry adoption of technology in healthcare is driven by an increase in government mandates, staffing shortages, improving clinical outcomes, and increasing pressures...
EMR 2019: The Market for Electronic Medical Records
Published: April 23, 2019 | Price: $5,000 – $10,000
EMR 2019 represents the twelfth time that Kalorama Information has created a detailed study of the electronic medical records (EMR) industry. The report looks at the market and trends affecting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics, life expectancy, and company strategies. This 450-page report is a complete global analysis of the EMR / EHR market. A market summary includes a total market analysis, including: EMR Market Analysis 2018-2023 ($...
EMR Market 2017: Electronic Medical Records in an Era of Disruption
Published: April 18, 2017 | Price: $3,196 – $6,392
EMR Market 2017: Electronic Medical Records Market in an Era of Disruption For a decade, the EMR market could be said to be growing market on a predictable trajectory. There is a great deal of competition, hundreds of scattered companies serving local or web markets, and a few large concerns that are capturing large institutions. There were government-funded physician and hospital incentives in the largest market of the United States, which transformed to potential penalties. All the while, some trends...
Hospital Acquired Infection (HAI) Control Markets
Published: February 22, 2017 | Price: $3,600 – $7,200
Hospital Acquired Infection (HAI) Control Markets Hospital Acquired Infection (HAI) Control Markets provides a revenue analysis for the prevention, testing, and treatment of infections in the healthcare surroundings, including the world revenues for 2010-2021 for hospital infection control, for hospital infection treatment, and for hospital infection prevention equipment and consumables (sterilization/disinfection). Sales information is also provided for the different market segments by primary geographic region (United States, Europe, rest of world) and leading manufacturers’ shares. Merck, Pfizer, GlaxoSmithKline, and Bayer...
Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)
Published: January 25, 2016 | Price: $3,360 – $6,720
Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing) This Kalorama Information report, Hospital-Acquired Infections takes a solid look at Hospital-Acquired Infection Statistics Device Sterilization Market Hospital Area Disinfection Market HAI Testing Market Treatment Market Market Segmentation by Healthcare Location: Hospital, Nursing Home, Other Market Segmentation by Geographic Location: US, EU, Asia, Other Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking...
Healthcare Associated Infection (HAI) Control Markets, Forecasts to 2020: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments
Published: May 7, 2014 | Price: $995 – $1,990
Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may occur in a postoperative wound or as a complication unrelated to the disease or condition. This report, Healthcare-Associated Infection (HAI) Control Markets: focuses on the market opportunities for companies that can assist hospitals and other healthcare facilities with important HAI mitigation tasks including: preventing, testing...
EMR in Europe
Published: October 15, 2012 | Price: $995 – $1,990
EMR in Europe This report, EMR Europe 2012 is a look at the market and trends impacting electronic medical record software and related services in Europe. Included in the report are statistics influencing the industry, demographics, and company strategies. A market summary includes a total market analysis. Also included is a snapshot look at individual countries’ demographics, healthcare spending, EMR adoption depth and competitive opportunities. Electronic Medical Records has been established in several European countries for the last decade or...
Hospital Acquired Infections: Testing Markets
Published: August 14, 2012 | Price: $3,995 – $7,990
A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections). The following are among the hospital infections considered in this report: Acinetobacter Baumannii Clostridium Difficile Hospital-Acquired Pneumonia Pseudomonas Aeruginosa...
Healthcare Computer System Markets and Trends in HIT Buying (Forecasts for System, Service and Support Revenues, Areas of interest, major competitor profiles)
Published: August 1, 2009 | Price: $1,995 – $7,000
The healthcare information technology (HIT) market was in a growth trend prior to the recent recession. While economic times have tightened budgets some, there is still opportunities for companies in this market. In this report, Kalorama takes a comprehensive look at the demand for IT products in the healthcare market - with a focus on computer systems for hospitals, nursing homes, physician offices and other healthcare entities. Kalorama has interviewed experts in the HIT industry and presents the latest findings...
Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
Published: April 1, 2009 | Price: $500 – $3,990
Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer's pocket? How will some novel trends (retail clinics, medical tourism) fit into this economy? It is commonly asserted that OTC and generic drugs sales will be boosted. Will this pan out? What will be the possible...
Growing “Out of Pocket” Healthcare Market (Spending on Surgeries, Pharmaceuticals and Other Healthcare Services), The
Published: November 1, 2007 | Price: $3,250 – $6,500
While insurance is the most common form of payment for healthcare services, increasingly customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies, should recognize that a part of their revenues are originating directly or indirectly from out of pocket expenditures. Health care costs are high and accelerating as a result of a confluence of factors within the broader economy, as well as the health care marketplace. Unique financial services have been created to facilitate non-insurance-paid health care...
Healthcare Opportunities for Food Ingredient Manufacturers
Published: October 1, 2007 | Price: $995 – $1,990
For food ingredient companies willing to enter the non-food market, there is over a billion dollars of market potential awaiting them. In addition to increasing the profitability of their traditional product lines, producers of ingredients can potentially expand their markets by moving their products or byproducts into the healthcare sector, where drug producers or manufacturers of some biomedical devices could incorporate them into their products. Kalorama Information's Healthcare Opportunities for Food Ingredient Manufacturers details the sources of ancillary revenue that...
Hispanics and Healthcare: Understanding Demographics, Health Statistics, and Attitudes for More Effective Marketing
Published: May 1, 2005 | Price: $1,995 – $3,990
In the last decade the importance of reaching the Hispanic market has become increasingly apparent to marketing practitioners in all industries. Hispanics have not only increased in numbers to become the largest ethnic minority population in the United States, but also increased in purchasing power, representing an estimated $680 billion in 2004 and expected to grow at an average annual rate of 8%. For many industries, including pharmaceutical and healthcare, Hispanics constitute an unfamiliar segment of the market, but one...